πŸ‡ΊπŸ‡Έ FDA
Patent

US 7892554

Internalizing ErbB2 antibodies

granted A61KA61K31/704A61K38/00

Quick answer

US patent 7892554 (Internalizing ErbB2 antibodies) held by The Regents of the University of California expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/704, A61K38/00, A61K47/6809, A61K47/6843